The results bring Lilly one step closer to filing for approval of the injection, retatrutide, which works differently from existing injections and pills.

More News

Market

NVDA Stock: A GARP Play with Strong Growth and Reasonable Valuation

ZivFin Analysis2026.05.21

NVIDIA (NVDA) fits a Growth At A Reasonable Price (GARP) strategy, combining strong earnings growth with reasonable valuation. With a Growth rating of 9/10 and forward P/E of 19.32, it trades below industry peers. Strong profitability, low debt, and robust analyst expectations make it a compelling GARP candidate.

More News

Crypto

OSL Strengthens Asia’s Digital Asset Ecosystem with Listing of State-Supervised Gold-Backed Stablecoin USDKG

Cointelegraph2026.05.21

OSL Group (863.HK) (OSL), a global stablecoin payment and trading platform, today announced that its Hong Kong-licensed digital asset exchange OSL HK has officially listed USDKG, the gold-backed stablecoin issued by the Kyrgyz Republic.